Orbit develop and apply innovative drug discovery platforms defined by a unique peptide display engine that deliver novel, functional, biologically relevant peptide therapeutic leads. The Orbit peptide display engine is uniquely able to address cell-based targets and thereby screen targets in relevant contexts. Peptide leads are key starting points for the development of peptide, peptidomimetic and small molecule therapeutics as well as bioconjugates for cell targeting and cargo delivery. Founded in late 2015 as a spin-out from Oxford University based on the work of Professors Graham Ogg and Terry Rabbitts. We have a pipeline of novel targets in in-house programmes and we work in collaboration with others in industry and academia to make our technology as accessible as possible.
View Top Employees from Orbit DiscoveryWebsite | http://www.orbitdiscovery.com |
Revenue | $7 million |
Funding | $8.7 million |
Employees | 32 (32 on RocketReach) |
Founded | 2015 |
Phone | +44 1865 749234 |
Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Manufacturing |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies |
Looking for a particular Orbit Discovery employee's phone or email?
The Orbit Discovery annual revenue was $7 million in 2024.
Neil Butt is the CEO of Orbit Discovery.
32 people are employed at Orbit Discovery.
The NAICS codes for Orbit Discovery are [541, 541714, 54, 5417, 54171].
The SIC codes for Orbit Discovery are [873, 87].